Navigation Links
Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting

BIRMINGHAM, Ala., April 03, 2007 /PRNewswire/ -- Southern Research Institute, a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery and drug development today announced that its scientists will be delivering one oral presentation and 10 poster presentations at the 2007 American Association for Cancer Research (AACR) Annual Meeting, April 14-18 in Los Angeles, Calif.

Anshu Mittal Roy of Southern Research will be presenting new data on the different factors that contribute to tumor growth. The discussion titled "VEGF Overexpression Increases Stromal Content in Both Primary Tumor and Metastatic Lesions" will be presented on Tuesday, April 17, from 11:25 a.m. - 11:40 a.m. in Room 404 A-B, Los Angeles Convention Center.

Scientists from Southern Research will also present preclinical data in posters at the Exhibit Hall:

    Sunday, April 15

     -- Jose T. Thaiparambil will be presenting poster (#644) "Sulindac

        Sulfide Selectively Inhibits cGMP PDE from Human HT-29 Colon Tumor

        Cells" from 8:00 a.m. -12:00 p.m.


     -- Patricia E. Noker will be presenting poster (#1545) "Toxicity and

        Pharmacokinetics of 1-Methyl-D-Tryptophan in Rats and Dogs" from 1:00

        p.m. - 5:00 p.m.


    Monday, April 16

     -- Rongbao Li will be presenting poster (#3165) "Structural Basis for

        PYK2 Adhesion Targeting" from 1:00 p.m. - 5:00 p.m.


     -- Adam B. Keeton will be presenting poster (#2282) "Reversal of MRP-1

        Mediated Multi-Drug Resistance by Sulinda Sulfide and Indomethacin"

        from 8:00 a.m. - 12:00 p.m.


    Tuesday, April 17

     -- Bo Xu will be presenting poster (#3895) "Regulation of ATM

        Phosphorylation in the Absence of DNA Damage" from 8:00 a.m. - 12:00

        p.m.


     -- Mickael J. Cariveau will be presenting poster (#3893) "Interfering

        with NBS1-ATM Interaction to Inhibit the DNA Damage Response and

     
   Sensitize Tumor Cells to Radiation" from 8:00 a.m. - 12:00 p.m.


     -- Jaideep V. Thottassery will be presenting poster (#4375) "Cks1

        Regulates Cdk1 Expression: A novel Role during Mitotic Entry in Breast

        Cancer Cells" from 1:00 p.m. - 5:00 p.m.


     -- Yonghe Li will be presenting poster (#4385) "Opposing Roles of Dkk1 in

        LRP6 Stabilization and Wnt Signaling: Implication for Wnt Ligand-

        induced LRP6 Down-regulation" from 1:00 p.m. - 5:00 p.m.


     -- Zhican Qu will be presenting poster (#8935) "Screening for Specific

        Anti-angiogenic Agents" from 1:00 p.m. - 5:00 p.m.


    Wednesday, April 18

     -- Bo Xu will be presenting poster (#5055) "Clofarabine Acts

        Synergistically with Ionizing Radiation In Vitro and In Vivo by

        Inhibiting the Repair of DNA Damage" from 8:00 a.m. - 12:00 p.m.

To date, Southern Research has discovered six of the FDA-approved anti- cancer drugs and four additional drugs that are currently in clinical trials. Further, Southern Research has evaluated almost 70% of all other FDA-approved cancer drugs on the market. Seventy-five percent of all FDA approved HIV drugs have also been evaluated at Southern Research during development.

ABOUT SOUTHERN RESEARCH

Southern Research is a not-for-profit organization that conducts scientific research at facilities in Alabama, Florida, Maryland and North Carolina. Southern Research provides contract research in the fields of preclinical drug discovery and development, advanced engineering, environmental and energy-related research. For more information, see www.SouthernResearch.org.

    Media Contacts:


    Rhonda Jung                      Risa Burgess

    205-581-2317                     781-684-0770

    Southern Research Institute      Schwartz Communications, Inc.

            

Jung@SouthernResearch.org Southern@schwartz-pr.com

CONTACT: Rhonda Jung of Southern Research, +1-205-581-2317,; or Risa Burgess for Southern Research,+1-781-684-0770, Jung@SouthernResearch.org Southern@schwartz-pr.com

Web site: http://www.southernresearch.org/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Researchers Discover Method for Identifying How Cancer Evades the Immune System
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. Fact Sheet: Advancing Stem Cell Research While Respecting Moral Boundaries
8. President Bush Ignores Americas Plea for Support of Stem Cell Research
9. Researchers Discover Gene For Rare Skin Disorder
10. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
11. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... ... of the GlycoMark test throughout the Northeast U.S. , GlycoMark is the ... diabetes. The GlycoMark test provides a clinically proven one- to two-week measure of ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... and DENVER (PRWEB) , ... April 27, 2017 ... ... Health, the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement ... is enabled by the continuing support of the Jane and Leonard Korman Family ...
Breaking Medicine News(10 mins):